Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Terence Cook

Showing results (81-90 of 210) with videos related to

Pageof 21
Sort By:
European Journal of Immunology|November 2, 2004
Restoration of C1q levels by bone marrow transplantation attenuates autoimmune disease associated with C1q deficiency in miceJosefina Cortes-Hernandez, Liliane Fossati-Jimack, Franz Petry, et al.
The Journal of Investigative Dermatology|November 24, 2016
Complement C3 Exacerbates Imiquimod-Induced Skin Inflammation and Psoriasiform DermatitisChiara Giacomassi, Norzawani Buang, Guang Sheng Ling, et al.
The American Journal of Pathology|August 28, 2004
CD59a deficiency exacerbates ischemia-reperfusion injury in miceDaniel Turnberg, Marina Botto, Margarita Lewis, et al.
The American Journal of Pathology|June 7, 2011
AP-1 transcription factor JunD confers protection from accelerated nephrotoxic nephritis and control podocyte-specific Vegfa expressionH Terence Cook, Ruth Tarzi, Zelpha D'Souza, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 4, 2011
Stimulation of the PD-1/PDL-1 T-cell co-inhibitory pathway is effective in treatment of experimental autoimmune glomerulonephritisJohn Reynolds, Gregg S Sando, Olivia B Marsh, et al.
Kidney International Reports|November 9, 2019
Glomerular Complement Factor H-Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal ImpairmentNicholas R Medjeral-Thomas, Hilary Moffitt, Hannah J Lomax-Browne, et al.
Annals of the Rheumatic Diseases|June 7, 2013
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroidsMarie B Condon, Damien Ashby, Ruth J Pepper, et al.
Histopathology|March 5, 2021
Masked crystalline light chain tubulopathy and podocytopathy with focal segmental glomerulosclerosis: a rare MGRS-associated renal lesionAndreas Kousios, Stephen Mcadoo, Sarah Blakey, et al.
Rheumatology (Oxford, England)|August 29, 2015
Eculizumab as rescue therapy in severe resistant lupus nephritisMatthew C Pickering, Mediola Ismajli, Marie B Condon, et al.
Kidney International Reports|January 16, 2026
Characterizing the NIH Activity and Chronicity Indices in 2 Independent Lupus Nephritis CohortsValentina Querin, Natasha Jordan, David P D'Cruz, et al.
Pageof 21

Showing results (81-90 of 210) with videos related to

Sort By:
Pageof 21
European Journal of Immunology|November 2, 2004
Restoration of C1q levels by bone marrow transplantation attenuates autoimmune disease associated with C1q deficiency in miceJosefina Cortes-Hernandez, Liliane Fossati-Jimack, Franz Petry, et al.
The Journal of Investigative Dermatology|November 24, 2016
Complement C3 Exacerbates Imiquimod-Induced Skin Inflammation and Psoriasiform DermatitisChiara Giacomassi, Norzawani Buang, Guang Sheng Ling, et al.
The American Journal of Pathology|August 28, 2004
CD59a deficiency exacerbates ischemia-reperfusion injury in miceDaniel Turnberg, Marina Botto, Margarita Lewis, et al.
The American Journal of Pathology|June 7, 2011
AP-1 transcription factor JunD confers protection from accelerated nephrotoxic nephritis and control podocyte-specific Vegfa expressionH Terence Cook, Ruth Tarzi, Zelpha D'Souza, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 4, 2011
Stimulation of the PD-1/PDL-1 T-cell co-inhibitory pathway is effective in treatment of experimental autoimmune glomerulonephritisJohn Reynolds, Gregg S Sando, Olivia B Marsh, et al.
Kidney International Reports|November 9, 2019
Glomerular Complement Factor H-Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal ImpairmentNicholas R Medjeral-Thomas, Hilary Moffitt, Hannah J Lomax-Browne, et al.
Annals of the Rheumatic Diseases|June 7, 2013
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroidsMarie B Condon, Damien Ashby, Ruth J Pepper, et al.
Histopathology|March 5, 2021
Masked crystalline light chain tubulopathy and podocytopathy with focal segmental glomerulosclerosis: a rare MGRS-associated renal lesionAndreas Kousios, Stephen Mcadoo, Sarah Blakey, et al.
Rheumatology (Oxford, England)|August 29, 2015
Eculizumab as rescue therapy in severe resistant lupus nephritisMatthew C Pickering, Mediola Ismajli, Marie B Condon, et al.
Kidney International Reports|January 16, 2026
Characterizing the NIH Activity and Chronicity Indices in 2 Independent Lupus Nephritis CohortsValentina Querin, Natasha Jordan, David P D'Cruz, et al.
Pageof 21